Clinical Trial Update: Vaccine Treatment for Surgically Resected Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for a vaccine treatment in patients with surgically resected pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: NewLink Genetics Corporation | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED